Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
Mechanisms of aluminium neurotoxicity in oxidative stress-induced ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
REFERENCES<br />
Hughes A. J., Ben-Shlomo Y., Daniel S. E. and Lees A. J. (1992b) What features improve the<br />
accuracy <strong>of</strong> cl<strong>in</strong>ical diagnosis <strong>in</strong> Park<strong>in</strong>son’s disease: A cl<strong>in</strong>icopathologic study. Neurology<br />
42, 1142–1146.<br />
Hughes A. J., Daniel S. E. and Lees A. J. (1993) The cl<strong>in</strong>ical features <strong>of</strong> Park<strong>in</strong>son’s disease <strong>in</strong> 100<br />
histologically proven cases. Adv. Neurol. 60, 595–599.<br />
Hughes A. J., Daniel S. E. and Lees A.J. (2001) Improved accuracy <strong>of</strong> cl<strong>in</strong>ical diagnosis <strong>of</strong> Lewy<br />
body Park<strong>in</strong>son’s disease. Neurology 57, 1497–1499.<br />
Hughes A. J., Daniel S. E., Ben-Shlomo Y. and Lees A. J. (2002) The accuracy <strong>of</strong> diagnosis <strong>of</strong><br />
park<strong>in</strong>sonian syndromes <strong>in</strong> a specialist movement disorder service. Bra<strong>in</strong> 125, 861–870.<br />
Hunot S., Boissiere F., Faucheux B., Brugg B., Mouatt-Prigent A. and Agid Y. (1996) Nitric oxide<br />
synthase and neuronal vulnerability <strong>in</strong> Park<strong>in</strong>son’s disease. Neuroscience 72, 355–363.<br />
Hunot S., Dugas N., Faucheux B., Hartmann A., Tardieu M., Debre P., Agid Y., Dugas B. and<br />
Hirsch E. C. (1999) FcepsilonRII/CD23 is expressed <strong>in</strong> Park<strong>in</strong>son’s disease and <strong>in</strong>duces, <strong>in</strong><br />
vitro, production <strong>of</strong> nitric oxide and tumor necrosis factor-alpha <strong>in</strong> glial cells. J. Neurosci.<br />
19, 3440–3447.<br />
Iaccar<strong>in</strong>o C., Crosio C., Vitale C., Sanna G., Carri M. T. and Barone P. (2007) Apoptotic<br />
mechanisms <strong>in</strong> mutant LRRK2-mediated cell death. Hum. Mol. Genet. 16, 1319–1326.<br />
Ibañez P., Bonnet A. M., Debarges B. Lohmann E., Tison F., Pollak P., Agid Y., Dürr A. and Brice<br />
A. (2004) Causal relation between alpha-synucle<strong>in</strong> gene duplication and familial<br />
Park<strong>in</strong>son’s disease. Lancet 364, 1169–1171.<br />
Ichitani I., Okamura H., Matsumoto Y., Nagatsu I. and Ibata Y. (1991) Degeneration <strong>of</strong> the nigral<br />
dopam<strong>in</strong>e neurons after 6-hydroxydopam<strong>in</strong>e <strong>in</strong>jection <strong>in</strong>to the rat striatum. Bra<strong>in</strong> Res.<br />
549, 330–353.<br />
Ilic T. V., Jovanovic M., Jovicic A. and Tomovic M. (1999) Oxidative <strong>stress</strong> <strong>in</strong>dicators are<br />
elevated <strong>in</strong> de novo Park<strong>in</strong>son's disease patients. Funct. Neurol. 14, 141–147.<br />
205